MarketScale
‹ Back to Industries

Healthcare

Pharma Marketing’s New Frontier: Leveraging Content Subtype for Superior and Faster Reviews

The article discusses how strategic categorization of promotional materials can enhance the efficiency of pharmaceutical marketing approvals. Experts Annalise Ludtke and Dr. Joe DiCapite emphasize the importance of understanding job duration metrics by content subtype. Their analysis aids pharmaceutical companies in optimizing review processes and improving promotional strategies.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Annalise Ludtke · Benchmark DataDr. Joe DicapitePharmaceutical IndustryPromotional Review Process
Share

Key takeaways

01

Strategic categorization reduces review cycles.

02

Understanding metrics is crucial for efficient planning.

03

Different content types impact review durations.

Exploring the pivotal aspects of promotional content review in the pharmaceutical industry, the 2023 State of Promotional Review Benchmark Report presented in the Benchmarks Symposium series sheds light on the intricacies of job duration metrics by content subtype. Hosted by Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori, with the expertise of Dr. Joe DiCapite, the Director of Strategy at UK and Europe Vodori, this episode navigates through the diverse challenges and considerations involved in reviewing and approving various types of promotional content. Dr. DiCapite's rich background in pharmaceuticals provides a detailed perspective on the importance of understanding these metrics for efficient planning and benchmarking against industry standards.

By delving into factors that affect job duration, such as content complexity, size, and risk, the episode offers valuable insights into optimizing review processes.

The discussion emphasizes how different content types, from social media to videos and podcasts, impact review durations and highlights the significance of such data for strategic planning and process improvement. By delving into factors that affect job duration, such as content complexity, size, and risk, the episode offers valuable insights into optimizing review processes. This analysis not only aids pharmaceutical companies in enhancing their promotional strategies but also ensures that critical medications are efficiently delivered to the right patients. The emphasis on content subtype highlights the strategic value of benchmark data in the promotional review process, providing a roadmap for enhancing efficiency and effectiveness in pharmaceutical marketing.

About the author

AL
Annalise Ludtke

New to MarketScale?

MarketScale is the platform Healthcare companies use to turn their own experts into content like this. Want the short overview?

Request infoBook a demo

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

AL
Annalise Ludtke

Senior Manager of Marketing and Communications at Vodori

Annalise Ludtke is the Senior Manager of Marketing and Communications at Vodori. She specializes in enhancing communication strategies to improve compliance and efficiency in the pharmaceutical industry's promotional review process.

DJ
Dr. Joe DiCapite

Director of Strategy at UK and Europe

Vodori

Dr. Joe DiCapite has a rich background in pharmaceuticals, providing a detailed perspective on the importance of understanding promotional review metrics for strategic planning and process improvement.